CMMB
Price
$1.16
Change
+$0.01 (+0.87%)
Updated
Jul 3 closing price
Capitalization
22.23M
34 days until earnings call
DSGN
Price
$3.77
Change
+$0.09 (+2.45%)
Updated
Jul 3 closing price
Capitalization
214.02M
37 days until earnings call
Interact to see
Advertisement

CMMB vs DSGN

Header iconCMMB vs DSGN Comparison
Open Charts CMMB vs DSGNBanner chart's image
Chemomab Therapeutics
Price$1.16
Change+$0.01 (+0.87%)
Volume$39.71K
Capitalization22.23M
Design Therapeutics
Price$3.77
Change+$0.09 (+2.45%)
Volume$47.53K
Capitalization214.02M
CMMB vs DSGN Comparison Chart in %
Loading...
CMMB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
DSGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CMMB vs. DSGN commentary
Jul 05, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CMMB is a Hold and DSGN is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 05, 2025
Stock price -- (CMMB: $1.16 vs. DSGN: $3.77)
Brand notoriety: CMMB and DSGN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CMMB: 26% vs. DSGN: 47%
Market capitalization -- CMMB: $22.23M vs. DSGN: $214.02M
CMMB [@Biotechnology] is valued at $22.23M. DSGN’s [@Biotechnology] market capitalization is $214.02M. The market cap for tickers in the [@Biotechnology] industry ranges from $310.37B to $0. The average market capitalization across the [@Biotechnology] industry is $2.38B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CMMB’s FA Score shows that 1 FA rating(s) are green whileDSGN’s FA Score has 0 green FA rating(s).

  • CMMB’s FA Score: 1 green, 4 red.
  • DSGN’s FA Score: 0 green, 5 red.
According to our system of comparison, CMMB is a better buy in the long-term than DSGN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CMMB’s TA Score shows that 3 TA indicator(s) are bullish while DSGN’s TA Score has 4 bullish TA indicator(s).

  • CMMB’s TA Score: 3 bullish, 6 bearish.
  • DSGN’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, DSGN is a better buy in the short-term than CMMB.

Price Growth

CMMB (@Biotechnology) experienced а -2.82% price change this week, while DSGN (@Biotechnology) price change was -1.31% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +6.93%. For the same industry, the average monthly price growth was +17.38%, and the average quarterly price growth was -0.11%.

Reported Earning Dates

CMMB is expected to report earnings on Aug 08, 2025.

DSGN is expected to report earnings on Aug 11, 2025.

Industries' Descriptions

@Biotechnology (+6.93% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
DSGN($214M) has a higher market cap than CMMB($22.2M). CMMB YTD gains are higher at: -35.912 vs. DSGN (-38.898). CMMB has higher annual earnings (EBITDA): -14.18M vs. DSGN (-67.79M). DSGN has more cash in the bank: 230M vs. CMMB (10.6M). CMMB has less debt than DSGN: CMMB (292K) vs DSGN (2.14M). CMMB (0) and DSGN (0) have equivalent revenues.
CMMBDSGNCMMB / DSGN
Capitalization22.2M214M10%
EBITDA-14.18M-67.79M21%
Gain YTD-35.912-38.89892%
P/E RatioN/AN/A-
Revenue00-
Total Cash10.6M230M5%
Total Debt292K2.14M14%
FUNDAMENTALS RATINGS
CMMB: Fundamental Ratings
CMMB
OUTLOOK RATING
1..100
78
VALUATION
overvalued / fair valued / undervalued
1..100
29
Undervalued
PROFIT vs RISK RATING
1..100
99
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
63
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CMMBDSGN
RSI
ODDS (%)
Bullish Trend 3 days ago
78%
N/A
Stochastic
ODDS (%)
Bullish Trend 3 days ago
88%
Bullish Trend 3 days ago
85%
Momentum
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
84%
MACD
ODDS (%)
Bearish Trend 3 days ago
89%
Bearish Trend 3 days ago
83%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
84%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
85%
Advances
ODDS (%)
N/A
Bullish Trend 3 days ago
88%
Declines
ODDS (%)
Bearish Trend 9 days ago
90%
Bearish Trend 6 days ago
86%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
90%
Bullish Trend 3 days ago
81%
Aroon
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
88%
View a ticker or compare two or three
Interact to see
Advertisement
CMMB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
DSGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
FPRUF65.08N/A
N/A
Fraport AG
ARSEF0.04N/A
N/A
Altai Resources Inc.
UWHR9.50N/A
N/A
Uwharrie Capital Corp
ARGTF18.43-0.12
-0.65%
Artemis Gold Inc.
EVGGF81.73-0.54
-0.65%
Evolution AB

DSGN and

Correlation & Price change

A.I.dvisor indicates that over the last year, DSGN has been loosely correlated with VRDN. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if DSGN jumps, then VRDN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DSGN
1D Price
Change %
DSGN100%
+2.45%
VRDN - DSGN
49%
Loosely correlated
+2.89%
KRYS - DSGN
47%
Loosely correlated
+1.22%
IDYA - DSGN
46%
Loosely correlated
+0.82%
AURA - DSGN
46%
Loosely correlated
+1.55%
TRDA - DSGN
43%
Loosely correlated
N/A
More